SI1919474T1 - Derivati pirolopiridina in njihove uporabe kot modulatorji PPAR receptorja - Google Patents

Derivati pirolopiridina in njihove uporabe kot modulatorji PPAR receptorja

Info

Publication number
SI1919474T1
SI1919474T1 SI200630436T SI200630436T SI1919474T1 SI 1919474 T1 SI1919474 T1 SI 1919474T1 SI 200630436 T SI200630436 T SI 200630436T SI 200630436 T SI200630436 T SI 200630436T SI 1919474 T1 SI1919474 T1 SI 1919474T1
Authority
SI
Slovenia
Prior art keywords
ppar
alkyl
pyrrolopyridine derivatives
same
salts
Prior art date
Application number
SI200630436T
Other languages
English (en)
Slovenian (sl)
Inventor
Benaissa Boubia
Martine Barth
Jean Binet
Pierre Dodey
Christiane Legendre
Olivia Poupardin-Olivier
Original Assignee
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa
Publication of SI1919474T1 publication Critical patent/SI1919474T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
SI200630436T 2005-09-01 2006-08-31 Derivati pirolopiridina in njihove uporabe kot modulatorji PPAR receptorja SI1919474T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71345905P 2005-09-01 2005-09-01
FR0510482A FR2890072A1 (fr) 2005-09-01 2005-10-14 Nouveaux composesde pyrrolopyridine
EP06808267A EP1919474B1 (fr) 2005-09-01 2006-08-31 Derives de pyrrolopyridine et leurs utilisations comme modulateurs des recepteurs ppar

Publications (1)

Publication Number Publication Date
SI1919474T1 true SI1919474T1 (sl) 2009-12-31

Family

ID=37735036

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630436T SI1919474T1 (sl) 2005-09-01 2006-08-31 Derivati pirolopiridina in njihove uporabe kot modulatorji PPAR receptorja

Country Status (27)

Country Link
US (2) US7557122B2 (ko)
EP (1) EP1919474B1 (ko)
JP (1) JP5232000B2 (ko)
KR (1) KR101289589B1 (ko)
CN (1) CN101242833B (ko)
AT (1) ATE438396T1 (ko)
AU (1) AU2006286348B2 (ko)
BR (1) BRPI0615335A2 (ko)
CA (1) CA2620662C (ko)
DE (1) DE602006008320D1 (ko)
DK (1) DK1919474T3 (ko)
EA (1) EA014185B1 (ko)
ES (1) ES2331336T3 (ko)
FR (1) FR2890072A1 (ko)
HK (1) HK1116698A1 (ko)
HR (1) HRP20090512T1 (ko)
IL (1) IL189189A (ko)
MX (1) MX2008003038A (ko)
MY (1) MY142983A (ko)
NO (1) NO340681B1 (ko)
PL (1) PL1919474T3 (ko)
PT (1) PT1919474E (ko)
SI (1) SI1919474T1 (ko)
TN (1) TNSN08091A1 (ko)
UA (1) UA92026C2 (ko)
WO (1) WO2007026104A1 (ko)
ZA (1) ZA200801885B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007145434A (ru) * 2005-05-10 2009-06-20 Вертекс Фармасьютикалз Инкорпорейтед (Us) Бициклические производные в качестве модуляторов ионных каналов
FR2890071B1 (fr) * 2005-08-30 2007-11-09 Fournier Sa Sa Lab Nouveaux composes de l'indole
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
JP2010528991A (ja) * 2007-05-21 2010-08-26 エスジーエックス ファーマシューティカルズ、インコーポレイテッド 複素環式キナーゼ調節因子
FR2955110A1 (fr) * 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
FR2955108B1 (fr) 2010-01-08 2012-03-16 Fournier Lab Sa Utilisation de derives de pyrrolopyridine comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
WO2013122897A1 (en) * 2012-02-13 2013-08-22 Amgen Inc. Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
WO2013134518A1 (en) 2012-03-09 2013-09-12 Amgen Inc. Sulfamide sodium channel inhibitors
GB201317363D0 (en) * 2013-10-01 2013-11-13 Eisai Ltd Novel compounds
CN103630519A (zh) * 2013-12-03 2014-03-12 华东理工大学 应用pH敏感的比率荧光蛋白检测酶-前药反应的方法
CN108164528B (zh) * 2018-03-31 2019-03-22 杭州巴洛特生物科技有限公司 一种酰胺类衍生物及其在高血压、高血脂和动脉粥样硬化中的应用
CN108456207B (zh) * 2018-03-31 2020-11-20 浙江药苑生物科技有限公司 一种酰胺类衍生物及其在心脑血管方面的应用
CN108218865B (zh) * 2018-03-31 2020-06-26 济南市儿童医院 一种酰胺类衍生物及其在心脑血管方面的应用
CN108383838B (zh) * 2018-03-31 2020-08-28 浙江药苑生物科技有限公司 一种酰胺类衍生物及其在高血压、高血脂和动脉粥样硬化中的应用
CN111793066B (zh) * 2020-07-17 2022-04-08 瀚海新拓(杭州)生物医药有限公司 苯并五元杂环磺酰胺类化合物、其制备方法、药物组合物及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997028149A1 (en) 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
EA002817B1 (ru) 1996-12-13 2002-10-31 Авентис Фармасьютикалз Продактс Инк. Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)азагетероциклиламида
WO2001060807A1 (en) 2000-02-18 2001-08-23 Merck & Co. Inc. Aryloxyacetic acids for diabetes and lipid disorders
WO2002071827A2 (en) 2001-03-14 2002-09-19 Eli Lilly And Company Retinoid x receptor modulators
MXPA04004711A (es) * 2001-11-19 2005-08-16 Neurogen Corp Amidas del acido 1h-pirrolo(3,2-b(piridin-3-carboxilico.
DE10229777A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Indolin-Phenylsulfonamid-Derivate
DE10300099A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Indol-Phenylsulfonamid-Derivate
US20050014753A1 (en) * 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
KR20130023381A (ko) * 2003-07-17 2013-03-07 플렉시콘, 인코퍼레이티드 Ppar 활성 화합물
DE10335449A1 (de) 2003-08-02 2005-02-17 Bayer Healthcare Ag Bicyclische Indolinsulfonamid-Derivate
DE10335450A1 (de) 2003-08-02 2005-02-17 Bayer Ag Indolin-Sulfanilsäureamide
EP1689389A4 (en) 2003-12-04 2009-06-17 Nat Health Research Institutes Indole compounds

Also Published As

Publication number Publication date
HK1116698A1 (en) 2009-01-02
US7557122B2 (en) 2009-07-07
BRPI0615335A2 (pt) 2012-12-11
ATE438396T1 (de) 2009-08-15
ES2331336T3 (es) 2009-12-29
UA92026C2 (uk) 2010-09-27
FR2890072A1 (fr) 2007-03-02
DE602006008320D1 (de) 2009-09-17
DK1919474T3 (da) 2009-11-09
JP5232000B2 (ja) 2013-07-10
AU2006286348A1 (en) 2007-03-08
AU2006286348B2 (en) 2012-04-26
EA200800352A1 (ru) 2008-06-30
EP1919474A1 (fr) 2008-05-14
JP2009507007A (ja) 2009-02-19
CN101242833A (zh) 2008-08-13
US7728002B2 (en) 2010-06-01
NO340681B1 (no) 2017-05-29
ZA200801885B (en) 2009-08-26
CA2620662C (fr) 2015-10-06
WO2007026104A1 (fr) 2007-03-08
IL189189A0 (en) 2008-06-05
IL189189A (en) 2013-10-31
CA2620662A1 (fr) 2007-03-08
CN101242833B (zh) 2012-06-27
PT1919474E (pt) 2009-10-28
KR20080039908A (ko) 2008-05-07
EA014185B1 (ru) 2010-10-29
TNSN08091A1 (fr) 2009-07-14
MX2008003038A (es) 2008-03-24
EP1919474B1 (fr) 2009-08-05
NO20080497L (no) 2008-02-29
MY142983A (en) 2011-02-14
US20090239856A1 (en) 2009-09-24
PL1919474T3 (pl) 2010-03-31
HRP20090512T1 (hr) 2009-12-31
KR101289589B1 (ko) 2013-07-24
US20080200495A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
IL189189A0 (en) Pyrrolopyridine derivatives and use of same as ppar receptor modulators
IL189183A0 (en) Novel indole compounds
MY154836A (en) Activating agent for peroxisome prolifrator activated receptor ?
DK1349843T3 (da) Thiazol- og oxazolderivater som aktivatorer af human peroxisom profilerator-aktiverede receptorer
DE60018064D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
EP1690538A4 (en) ISOXAZOLE DERIVATIVE AGONISTIC ACTION AGAINST PEROXISOM PROLIFERATOR ACTIVATED RECEPTOR
NO20062030L (no) Derivater av N-heterocyklylmetylbenzamider, fremgangsmate for fremstilling derav og anvendelse av forbindelsene t terapeutiske midler.
AR056574A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
WO2009064747A3 (en) 4(-3-(-2-(phenyl) morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl) benzenesulfon amide derivatives and related compounds as modulators of ion channels for the treatment of pain
PL378130A1 (pl) Pochodne kwasu 3-(2-fenylooksazol-4-ilometoksy)-cykloheksylometoksyoctowego i związki pokrewne, jako modulatory PPAR do leczenia cukrzycy typu 2 i stwardnienia naczyń
AU2003294082A1 (en) Composition comprising a carbamic acid derivative, its use as cosmetic and medicine
PT1828125E (pt) Derivados de arilpiperazina e sua utilização como ligantes selectivos do receptor d3 da dopamina
WO2006026034A3 (en) Processes for the preparation of isothiazole derivatives
AU2003207808A1 (en) Peroxisome proliferator activated receptor modulators
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
WO2008146917A1 (ja) リンコマイシン誘導体及びこれを有効成分とする抗菌剤
DK0829470T3 (da) 2-Cyano-3,5-dihydroxy-hex-2-en-carboxylsyreamidderivater, fremgangsmåde til deres fremstilling og deres anvendelse som læge
CA2490152A1 (en) Oxazole derivatives and their use as insulin sensitizers
FR2869903A1 (fr) Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppary, leur procede de preparation et leur utilisation dans les compositions cosmetiques ou pharmaceutiques
CA2314541A1 (fr) Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
AR022352A1 (es) COMPUESTOS HERBICIDAS DE ÁCIDO PROPIoNICO ALCOXICARBONIL ANILIDA ALTAMENTE SELECTIVOS, SUS COMPOSICIONES HERBICIDAS, SUS MÉTODOS DE PREPARACIoN Y COMPUESTO INTERMEDIARIO Y MÉTODO PARA CONTROLAR EL PASTO.
IL181010A0 (en) 2-{3,'2- (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes
IT1302700B1 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
YU89903A (sh) Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa
TH71078A (th) อนุพันธ์ซับสทิทิวเทด 3-(เบนโซอิลยูริไอโด)ไธโอฟีน, กรรมวิธีสำหรับการเตรียมอนุพันธ์เหล่านี้ และการใช้อนุพันธ์เหล่านี้